Navigation Links
Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
Date:8/3/2011

NEW YORK, Aug. 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - what are the revenue prospects?

http://www.reportlinker.com/p0578544/Lyophilisation-for-Pharmaceuticals-Technology-and-Services-Market-2011-2021---what-are-the-revenue-prospects.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

What are the commercial prospects for lyophilisation technology? Our new report shows you potential revenues to 2021. You will find discussions of opportunities and trends. Through our research and analysis we aim to save you time and help in your decisions.

Our report covers lyophilisation (cryodesiccation or freeze drying) in pharmaceutical applications: technologies, products and services. You will assess events, opportunities and activities shaping the lyophilisation industry and market from 2011 to 2021. 

You will find potential revenues for lyophilisation at total world, submarket and national levels to 2021. What technologies and applications will expand that market? What are the main therapeutic and commercial trends to watch? You will find predictions and answers.

There will be rising demand for drugs and vaccines harnessing drying technologies. There are needs for improved stability and cost effectiveness, as well as for more convenience in transport, storage and use of therapeutic agents. Our report shows you the opportunities.

From 2011 onwards there will be developments in freeze drying technology that will benefit the industry and its customers, extending performance and applications. You will see where those technologies are heading. Our study provides data and answers.

We provide many analyses. You will receive market forecasts for cGMP lyophilisers, laboratory lyophilisers and lyophilisation services. We discuss GEA Lyophil, Labconco Corporation, Vetter Pharma-Fertigung, Piramal Pharma Solutions and other companies. 

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Original analysis with revenues, growth rates, market shares, opinion and discussions 

You will find revenue forecasts, growth rates, market shares, a SWOT/STEP review, opinions from our survey and discussions of technologies and companies. We provide 62 tables and charts and three research interviews (shown in the accompanying lists).

Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 shows you opportunities, challenges and revenue forecasts

Our report gives you the following advantages:

• You will discover revenue forecasts to 2021 for the world lyophilisation products and services market, seeing where the highest revenue growth will occur

• You will discover revenue forecasts to 2021 for sub-markets, with discussions

• You will discover revenue forecasts to 2021 for leading national markets - US, Japan, UK, Germany, France, Spain, Italy, China and India - seeing growth trends

• You will assess leading companies providing lyophilisation technologies, discovering their activities and commercial outlooks

• You will discover the prospects for relevant therapeutic classes, with forecasts to 2021 and other data

• You will investigate opportunities influencing the development of lyophilisation technology and outsourcing from 2011 onwards

• You will see what stimulates and restrains the lyophilisation technology and services market, from the present looking ahead

• You will analyse opportunities and challenges for established companies and those seeking to enter the lyophilisation market

• You will view opinions from our industry survey, receiving full interview transcripts.

That mix of quantitative and qualitative analysis sets our report apart. We tackle crucial questions, helping you to stay ahead. You will discover trends in freeze drying products and services through predictions found only in our work.

Order our report now to gain industry and market analysis for lyophilisation

Our report is for everybody interested in market analysis and product/service development for freeze drying technologies. You will find predictions and answers. Don't miss out - please order our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

NB: All visiongain reports are password locked so please let us know what licence is most suitable for your business needs

Table of Contents

1. Executive Summary

1.1 Lyophilisation Market Review

1.2 Aims, Scope and Format of the Report

1.2.1 Chapter Outlines

1.3 Research and Analysis Methods

2. Introduction to Lyophilisation (Freeze Drying)

2.1 Introduction

2.1.1 What is Freeze Drying?

2.1.2 Why Freeze Dry?

2.1.3 A Brief History

2.2 General Description of the Process

2.2.1Freezing

2.2.2 Primary Drying (Sublimation) 

2.2.3 Secondary Drying (Desorption) 

2.3 Freeze Drying Equipment

2.3.1 Components of the Freeze Dryer

2.3.1.1 Drying Chamber

2.3.1.2 Condenser 

2.3.1.3 Vacuum Pump

2.3.1.4 Refrigeration System

2.3.1.5 Control Facilities

2.4 Type of Freeze Dryers

2.4.1Rotary Freeze Dryers 

2.4.2 Manifold Freeze Dryers 

2.4.3 Tray Freeze Dryers 

2.5 Applications of Lyophilisation

2.5.1 Pharmaceutical and Biotechnology Industry

2.5.2 Other Chemical and Technological Sectors

2.5.3 Veterinary Applications

2.5.4 Food Industry Applications

2.5.5 What Products Are Freeze Dried?

2.5.6 How do Freeze Dryers for Food Differ from those for Pharmaceutical Applications?

2.5.7 Other Applications for Lyophilisation

3. Lyophilisation Technology and Services Market, 2010-2021

3.1 Scope and Limitations

3.2 The World Lyophilisation Technology and Services Market in 2010

3.2.1 Marketed Lyophilised Drugs, 2010

3.2.2 Total Lyophilisation Market was Worth $1.99bn in 2010

3.3 Sales Forecast for Overall Lyophilisation Market, 2010-2015

3.4 Sales Forecast for Overall Lyophilisation Market, 2016-2021

3.5 Breakdown of the Global Lyophilisation Market

3.5.1 Sales Forecast for cGMP Lyophilisers, 2011-2021

3.5.2 Sales Forecast for Laboratory Lyophilisers, 2011-2021

3.5.3 Sales Forecast for Lyophilisation Services, 2011-2021

3.6 Leading National Markets for Lyophilisation Technology and Services, 2010

3.6.1 Leading National Markets for Lyophilisation Technology and Services: Sales Forecast, 2011-2021

3.6.2 The US Lyophilisation Technology and Services Market, 2011-2021

3.6.3 The Japanese Lyophilisation Technology and Services Market, 2011-2021

3.6.4 The Leading European Lyophilisation Technology and Services Markets, 2011-2021

3.6.5 Emerging Economy Lyophilisation Technology and Services Markets

3.6.6 The Chinese Lyophilisation Technology and Services Market, 2011-2021

3.6.7 The Indian Lyophilisation Technology and Services Market, 2011-2021

4. Worldwide Market for Lyophilised Products and Technology

4.1 Therapeutic Areas Offering Growth Opportunities

4.2 Development of Biologics and Vaccines Will Drive the Lyophilisation Market, 2011-2021

4.3 The Leading Sectors of Biological Drugs Market in 2010

4.3.1 Monoclonal Antibodies Currently Lead the Biotech Market

4.3.1.1 Long-Term Prospects for Monoclonal Antibodies and Implications for the Lyophilisation Market

4.3.2 The Human Insulins Class Will Exhibit Strong Growth 

4.3.3 Erythropoietin Products - How Will Reported Safety Affect Sales?

4.3.3.1 Erythropoietin Products Forecast, 2011-2021

4.3.4 The Interferons Class will Show an Increase in Revenues from 2010-2015

4.3.4.1 Long-Term Forecast for the Interferons Class

4.3.5 Granular-Colony Stimulating Factors (G-CSF), 2011-2021

4.3.6 Recombinant Coagulation Factors Will Show Steady Growth

4.3.7 Other Therapeutic Proteins

4.3.8 Biosimilars Market, 2010

4.3.8.1 Forecast for the Biosimilars Market, 2011-2021

4.3.9 Vaccines Market, 2010-2021

5. Systems, Consumables and Service Providers in the Lyophilisation Industry and Market

5.1 Products and Services in the Lyophilisation Market

5.1.1 Equipment Providers

5.1.2 Consumables Providers

5.1.3 Contract Manufacturing Organisations (CMOs) Providing Lyophilisation Services

5.2 Profiles of Some Leading Companies

5.2.1 GEA Lyophil

5.2.1.1 Overview

5.2.1.2 Capabilities of GEA Lyophil

5.2.1.3 GEA Lyophil's Research and Development Freeze Dryers

5.2.1.4 GEA Lyophil's Pilot Freeze Dryers

5.2.1.5 GEA's Lyovac Production Lyophilisers

5.2.1.6 Lyophilisation Production Systems

5.2.1.7 GEA's Retrofits of Lyophilisers

5.2.1.8 GEA's VAPOVAC: Technology for Freeze Dryer Sterilisation

5.2.1.9 ALUS: GEA Lyophil's Automatic Loading and Unloading Systems for Lyophilisers

5.2.1.10 GEA's Thermodynamic Lyophilisation Control

5.2.1.11 GEA Lyophil's Fast Track Project Management 

5.2.2 Labconco Corporation

5.2.2.1 Overview 

5.2.2.2 Global Presence

5.2.2.3 Product Focus

5.2.2.4 Dry Ice Benchtop Freeze Dry System 

5.2.2.5 FreeZone Benchtop Freeze Dry Systems 

5.2.2.6 FreeZone Console Freeze Dry Systems 

5.2.2.7 FreeZone Plus Cascade Freeze Dry Systems 

5.2.2.8 FreeZone Triad Freeze Dry Systems 

5.2.2.9 Labconco Freeze Dry Accessories

5.2.2.10 R&D

5.2.2.11 Future Outlook

5.2.3 Vetter Pharma-Fertigung

5.2.3.1 An Overview

5.2.3.2 Global Presence

5.2.3.3 Business Interests

5.2.3.3.1 Vetter Development Service 

5.2.3.3.2 Vetter Commercial Manufacturing 

5.2.3.3.3 Vetter Solutions

5.2.3.4 Capabilities

5.2.3.5 R&D

5.2.3.6 Product Focus

5.2.3.6.1 Dual-Chamber Technology

5.2.3.7 Future Outlook

5.2.4 Piramal Pharma Solutions

5.2.4.1 Overview

5.2.4.2 Global Presence

5.2.4.3 Strengths and Capabilities

6. SWOT Analysis of the Lyophilisation Technology Market

6.1 Introduction

6.2 Commercial Drivers of the Lyophilisation Technology Market

6.3 Commercial Restraints for the Lyophilisation Technology Market

6.3.1 High Entry Barriers to Sector

6.3.2 Product Formulation Challenges

6.3.3 R&D Stage for Lyophilised Products 

6.3.4 Scale-up Stage for Lyophilised Products 

6.3.5 Main Issues at Large Scale Production Stage for Lyophilised Products

6.3.6 Main Challenges in a Freeze Drying Plant

6.3.7 Main Issues in Production

6.3.8 Typical Deficiencies in a Freeze Drying Process 

6.4 Challenges Facing the Lyophilisation Technology Industry and Market

6.4.1 Spray Drying of Biopharmaceuticals

6.4.2 Other Methods in Development

6.4.2.1 Roche's Precipitation Method

7. Opinion from Our Survey of the Industry

7.1 Interview with Ms Jennifer Thompson, VP Corporate Development & Investor Relations, EnWave Corporation and Ms Florian Loesch, Sales Manager, Optima Pharma Group

7.1.1 Market for Lyophilised Products and Outsourcing of Lyophilisation Work

7.1.2 On the Key Unmet Needs and Driving Forces

7.1.3 Novel Dehydration Technologies in Development by EnWave Corporation

7.1.4 Development Status of bioREV and freezeREV Technology

7.1.5 On the Advantages Offered by bioREV and freezeREV

7.2 Authority from a Company in the Sector (Views Provided Anonymously)

7.2.1 Market for Lyophilised Products 

7.2.2 Outsourcing of Lyophilisation Work

7.2.3 On the Key Unmet Needs and Driving Forces

7.2.4 On the Capability and Capacity of the CMO

7.3 Interview with Dr Steven Nail, Baxter Healthcare Corporation, USA

7.3.1 Market Valuation for Freeze Drying?

7.3.2 Products Suitable for Lyophilisation

7.3.3 Percentage of Lyophilised Products on Market 

7.3.4 Key Areas for Research and Development

7.3.5 On Advantages of Lyophilisation

7.3.6 On Advantages of Lyophilisation over Other Drug Delivery Systems

7.3.7 On Drawbacks of Lyophilisation over Other Technologies

7.3.8 On Novel Technologies and Developments

8. Conclusions

8.1 Overview

8.2 Prominent Companies in the Market

8.3 Commercial Drivers of the Lyophilisation Market

8.4 Future Outlook and Concluding Remarks

List of Tables

Table 3.1 List of Some Lyophilised Orally Disintegrating Tablets, 2011

Table 3.2 World Lyophilisation Market by Leading Categories ($bn), 2010

Table 3.3 Lyophilisation Technology and Services: World Sales Forecast ($bn), 2010-2021

Table 3.4 Lyophilisation Technology and Services: World Sales Forecasts for Submarkets ($bn), 2010-2021

Table 3.5 cGMP Lyophilisers: World Sales Forecast ($bn), 2010-2021

Table 3.6 Laboratory Lyophilisers: World Sales Forecast ($bn), 2010-2021

Table 3.7 Lyophilisation Services Market: World Sales Forecast ($bn), 2010-2021

Table 3.8 Leading National Markets for Lyophilisation Technology and Services ($bn), 2010

Table 3.9 Leading Lyophilisation National Market Forecasts, 2010-2021

Table 3.10 Leading National Markets: Market Shares (%), 2010, 2015 & 2021

Table 4.1 Leading Product Classes Driving the Lyophilisation Market, 2010

Table 4.2 List of Some Currently Marketed Lyophilised Monoclonal Antibodies, 2011

Table 4.3 Monoclonal Antibodies Market: World Sales Forecast ($bn), 2010-2021

Table 4.4 Insulins Market: World Sales Forecast ($bn), 2010-2021

Table 4.5 Erythropoietins Market: World Sales Forecast ($bn), 2010-2021

Table 4.6 List of Some Currently Marketed Lyophilised Interferon Drugs, 2011

Table 4.7 Interferons Market: World Sales Forecast ($bn), 2010-2021

Table 4.8 G-CSF Market: World Sales Forecast ($bn), 2010-2021

Table 4.9 List of Some Currently Marketed Lyophilised Recombinant Coagulation Factors, 2011

Table 4.10 Recombinant Coagulations Factors Market: World Sales Forecast ($bn), 2010-2021

Table 4.11 List of Some Currently Marketed Lyophilised Human Growth Hormones, 2011

Table 4.12 List of Some Currently Marketed Lyophilised Immunosuppressants, 2011

Table 4.13 Other Therapeutic Proteins Market: World Sales Forecast ($bn), 2010-2021

Table 4.14 List of Some Currently Marketed Lyophilised Biosimilar Drugs, 2011

Table 4.15 Biosimilars Market: World Sales Forecast ($bn), 2010-2021

Table 4.16 List of Some Currently Marketed Lyophilised Vaccines, 2011

Table 4.17 Total Vaccines Market: World Sales Forecast ($bn), 2010-2021

Table 5.1 Companies that Provide Freeze Dryers and Associated Systems to the Pharmaceutical Industry, 2011

Table 5.2 Companies Providing Vials Suitable for Lyophilisation, 2011

Table 5.3 CMOs Providing Lyophilisation Services, 2011

Table 5.4 GEA Pharma Systems: A Historical Perspective

Table 5.5 Labconco Corporation: A Brief History

Table 6.1 SWOT Analysis of the Lyophilisation Industry and Market, 2011-2021

Table 6.2 Comparison between Lyophilisation and Spray Drying, 2011

Table 6.3 Advantages of a Spray Dryer for Drying Applications, 2011

Table 8.1 Lyophilisation Market: World Sales Forecasts, 2010, 2012, 2015, 2018 and 2021

List of Figures

Figure 2.1 The Primary Steps in Freeze Drying

Figure 2.2 Typical Lyophilisation (Freeze Drying) Process 

Figure 2.3 Components of a Typical Freeze Dryer

Figure 3.1 World Lyophilisation Market Shares (%) by Leading Categories, 2010

Figure 3.2 Lyophilisation Technology and Services: World Sales Forecast ($bn), 2010-2021

Figure 3.3 Lyophilisation Market: World Sales Forecast ($bn), 2010-2021

Figure 3.4 cGMP Lyophilisers: World Sales Forecast ($bn), 2010-2021

Figure 3.5 Laboratory Lyophilisers: World Sales Forecast ($bn), 2010-2021

Figure 3.6 Lyophilisation Services Market: World Sales Forecast ($bn), 2010-2021

Figure 3.7 Lyophilisation Sales Shares (%) in Leading National Markets, 2010

Figure 3.8 Lyophilisation Sales Shares (%) in Leading National Markets, 2015

Figure 3.9 Lyophilisation Sales Shares (%) in Leading National Markets, 2021

Figure 3.10 The US Lyophilisation Technology and Services Market Forecast ($bn), 2010-2021

Figure 3.11 The Japanese Lyophilisation Technology and Services Market Forecast ($bn), 2010-2021

Figure 3.12 Leading European Lyophilisation Technology and Services Markets: Forecasts ($bn), 2010-2021

Figure 3.13 The Chinese and Indian Lyophilisation Technology and Services Markets: Forecasts ($bn), 2010-2021

Figure 4.1 Monoclonal Antibodies Market: World Sales Forecast ($bn), 2010-2021

Figure 4.2 Insulins Market: World Sales Forecast ($bn), 2010-2021

Figure 4.3 Erythropoietins Market: World Sales Forecast ($bn), 2010-2021

Figure 4.4 Interferons Market: World Sales Forecast ($bn), 2010-2021

Figure 4.5 G-CSF Market: World Sales Forecast ($bn), 2010-2021

Figure 4.6 Recombinant Coagulation Factors Market: World Sales Forecast ($bn), 2010-2021

Figure 4.7 Other Therapeutic Proteins Market: World Sales Forecast ($bn), 2010-2021

Figure 4.8 Biosimilars Market: World Sales Forecast ($bn), 2010-2021

Figure 4.9 Total Vaccines Market: World Sales Forecast ($bn), 2010-2021

Figure 8.1 Lyophilisation Market: World Sales Forecast, 2010, 2012, 2015, 2018 and 2021

Companies Listed

AAIPharma Services

Abbott

ACMAS Technocracy

Affinity Life Sciences

Albany Molecular Research Inc. (AMRI) 

ALK-Abello

Althea Technologies

Amgen

Amsco International Corporation

Astellas Pharma

Baxter BioPharma Solutions

Baxter International

Bayer HealthCare Pharmaceuticals

Ben Venue Laboratories

Berna Biotech

Bilcare Global Clinical Supplies

Bio Sidus 

Biogen Idec

BIOLYPH

BioPartners

Biopharma Technology

Boehringer Ingelheim

Cangene bioPharma

Catalent Pharma Solutions

Centocor Ortho Biotech

Centre for Biologics Evaluation and Research

Cephalon

Changzhou Yibu Drying Equipment Co.

Chemisch-Pharmazeutisches Laboratorium Ravensburg 

CIMA Labs

CMC Biologics

Coldstream Laboratories

Cole-Parmer Instrument Company

Corden Pharma

CoreRx Pharmaceuticals 

Creapharm

CSL Behring

CSL Biotherapies

CT Arzneimettel

Cuddon Freeze Dry

Document Conservation Laboratory (DCL)

Dong-A

DSM Pharmaceuticals

E.R. Squibb & Sons

Eli Lilly and Company

EMD Serono

EnWave Corporation

Eurogentec

European Freeze Dry

European Medicines Agency (EMA)

Famar Health Care Services

Finn-Aqua Santasalo-Sohlberg Corporation

Food and Drug Administration (US FDA)

Formatech

Freeze Dryer Systems Europe

Freezedry Specialties

Fresenius Kabi Product Partnering

Frozen In Time

Gate Pharmaceuticals

GE Healthcare

GEA Lyophil

GEA Niro

GEA Pharma Systems

Genentech

GeneScience

Getz Pharma Research

GIPHARMA

Girindus

Gland Pharma Limited

GlaxoSmithKline

GP Pharm

Grand River Aseptic Manufacturing

Haake Buchler Instruments

Haupt Pharma

HollisterStier Laboratories

Hosokawa Micron Powder Systems

Hospira

HTD Biosystems

Hull

Human Genome Sciences

I.M.A. Industria Macchine Automatiche

IDT Biologika

ilShinBioBase

Immunex Corporation

Intas Biopharmaceuticals

Intelligent Pharma 

Irvine Pharmaceutical Services

Janssen Cilag

JHP Pharmaceuticals

Jubilant Life Sciences

KP Pharmaceutical Technology

Labconco Corporation

Legacy Pharmaceuticals International

Leybold

LG Life Sciences

LifeScientz Bio-tech Co.

Lonza

Lyka Labs

Lyofal

Lyophilization Services of New England

Lyophilization Technology

Martin Christ Gefriertrocknungsanlagen

MechaTech Systems 

Merck & Co.

Merck Sharp & Dohme Corporation

Merk Process

Millrock Technology

Miltenyi Biotec

National Archives and Records Administration (NARA)

Nextar Chempharma Solutions

NextPharma Technologies

Nicholas Piramal India Limited (NPIL)

Novartis

Novartis Vaccines and Diagnostics

Novo Nordisk

Oakwood Laboratories

OctoPlus

One 2 One

Optima Pharma Group

Oregon Freeze Dry

Organon Teknika Corporation 

Oso BioPharmaceuticals Manufacturing

Patheon

Peptisyntha (a part of Solvay Group)

Pfizer

Pfizer CentreSource (PCS)

Pharmatek Laboratories

PharmIdea

Piramal Diagnostic Services Private Limited

Piramal Group

Piramal Healthcare (PHL)

Piramal Pharma Solutions

ProJect Pharmaceutics

Pyramid Laboratories

Quorum Technologies

Recipharm Cobra Bio

Regeneron Pharmaceuticals

Reig Jofre Group

Research Foundation for Microbial Diseases of Osaka University

RK Medicare Private Limited

Roch Mechatronics

Roche

SAFC

Sandoz (a Novartis company)

Sanofi

Sanofi Pasteur

Schering Corporation

Schering Plough HealthCare Products

SCHOTT AG

Serail

SGD Pharma

SL Pharma Labs

Solvay Group

SP Industries 

SP Scientific

SPI Pharmaceuticals

Steris Corporation

Talecris Biotherapeutics

Telstar

Teva Pharmaceutical Industries

The University of Iowa Pharmaceuticals

Therapure Biopharma

Thermo Fisher Scientific

UCB

USIFROID (a Telstar company)

Valeant Pharmaceuticals

Vetter Pharma-Fertigung

Vetter Pharma International 

Wellspring

West Pharmaceutical Services

Wheaton Science Products

Wockhardt

Wyeth Pharmaceuticals Company

Xellia Pharmaceuticals 

Zirbus Technology

To order this report:

In Vitro Diagnostic Industry: Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - what are the revenue prospects?

In Vitro Diagnostic Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
2. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
3. Reportlinker Adds OTC Pharmaceuticals: Global Industry Almanac
4. Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets
5. Novel Technology Breaks Through Cancer Pain
6. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
9. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
10. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
11. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... LAS VEGAS , June 26, 2016 ... movement to value-based care operating models within the health ... that enable greater financial efficiency , Deloitte offers ... address the key business issues impacting efficient cost optimization: ... alignment , These services facilitate better outcomes and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):